Chan Mitchell

CIK 0001789335

Chief Financial OfficerDirector

Filings

Latest May 7, 2026

Issuers covered

Showing

11 of 11

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Chan Mitchell. Track record appears once open-market purchases or sales reach the +30 day horizon.

Companies where Chan Mitchell has filed

Ticker	Issuer	Filings	Last filed
AVTX	Avalo Therapeutics, Inc.	7	May 7, 2026
RGNX	Regenxbio Inc.	4	Jan 8, 2026

11 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
May 7, 2026	AVTXAvalo Therapeutics, Inc.	SSale	3,167	$22.88	$72,461
Mar 31, 2026	AVTXAvalo Therapeutics, Inc.	MExercise	3,166	-	-
Jan 8, 2026	RGNXRegenxbio Inc.	AGrant	73,749	$0.00	$0
Sep 3, 2025	RGNXRegenxbio Inc.	FTax	4,901	$8.93	$43,766
Jun 18, 2025	AVTXAvalo Therapeutics, Inc.	Holdings only	-	-	-
Apr 1, 2025	AVTXAvalo Therapeutics, Inc.	MExercise	3,167	-	-
Jan 6, 2025	RGNXRegenxbio Inc.	Holdings only	-	-	-
Sep 18, 2024	RGNXRegenxbio Inc.	AGrant	58,869	$0.00	$0
Aug 14, 2024	AVTXAvalo Therapeutics, Inc.	Holdings only	-	-	-
Dec 21, 2023	AVTXAvalo Therapeutics, Inc.	Holdings only	-	-	-
Jun 15, 2022	AVTXAvalo Therapeutics, Inc.	Holdings only	-	-	-

Showing 1-11 of 11

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.